TRBV25-1: Target/Biomarker Introduction, products summarized (antibody/ADC/bispecific/antigen/ORF vector/VLP) and disease/indication/condition/MOA for drug discovery and IVD

It’s the GeneMedi’s summary page for Target/Biomarker Introduction of TRBV25-1. The page also collects GeneMedi’s different modalities and formats products for TRBV25-1 in therapeutics/drug discovery and IVD diagnostics, which is including antibody, ADC, bispecific, antigen, ORF vector, VLP, etc. With GeneMedi’s target-insight database-GM ITD database, the TRBV25-1 target is also connected to human indications/diseases/conditions/MOA.

Target sublocation: Transmembrane Protein.

Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

Target ID
GM-MP1869

Target Name
TRBV25-1

Gene ID
28562

Gene Official Name
TRBV25-1

Gene Alias
TCRBV11S1A1T, TCRBV25S1, TRBV251

Protein Sub-location
Transmembrane Protein

Category

Anti-TVBY1/ TRBV25-1/ TCRBV11S1A1T antibody for FACS & in-vivo assay| GMab

Pre-made anti-TRBV25-1 benchmark inhibitory monoclonal antibody(mab, blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). The anti-TRBV25-1 mab is expressed and produced by mammalian cell line as a benchmark reference therapeutic antibody for biological drug discovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Filters Sort results
Reset Apply
Cat No.
Antibody Name
Format
Classified by tag
Order
GM-Tg-hg-MP1869-Ab
Anti-TRBV25-1 monoclonal antibody
mab
FACS/Biofunctional Antibody